Beta-glucan and Immune Response to Influenza Vaccine

Phase 2 Completed 78 enrolled University of Florida Danstar Ferment AG · collab

RandomizedParallel-groupTriple-blindOther

Summary

This trial in healthy adults will determine the effects of beta-glucan, a dietary fiber supplement isolated from baker's yeast, on immune response to the influenza vaccine.

Timeline

Start: 2022-07-18
Primary completion: 2024-03-01
Completion: 2024-08-28

Publications

Moreno ML, Nieves CJ, Hebert K, Vivas CA, Rivero-Mendoza D, Colee J, Tompkins TA, Dahl WJ. Yeast Beta-Glucan Enhances Antibody Response Following Influenza Vaccination - A Double-Blind, Randomized, Placebo-Controlled Pilot Trial. J Diet Suppl. 2025;22(5):795-810. doi: 10.1080/19390211.2025.2539876. Epub 2025 Jul 31.

Drugs

Evaluation	Drug	Modality	Dose	Route
Background	Influenza Virus Vaccine	Vaccine	—	—

Indications

No indication recorded.